JP2003522795A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003522795A5 JP2003522795A5 JP2001559472A JP2001559472A JP2003522795A5 JP 2003522795 A5 JP2003522795 A5 JP 2003522795A5 JP 2001559472 A JP2001559472 A JP 2001559472A JP 2001559472 A JP2001559472 A JP 2001559472A JP 2003522795 A5 JP2003522795 A5 JP 2003522795A5
- Authority
- JP
- Japan
- Prior art keywords
- norethisterone
- derivative
- testosterone undecanoate
- administration
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50372900A | 2000-02-15 | 2000-02-15 | |
| EP00200493.5 | 2000-02-15 | ||
| EP00200493 | 2000-02-15 | ||
| US09/503,729 | 2000-02-15 | ||
| PCT/IB2001/000188 WO2001060376A1 (en) | 2000-02-15 | 2001-02-15 | Male contraceptive formulation comprising norethisterone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003522795A JP2003522795A (ja) | 2003-07-29 |
| JP2003522795A5 true JP2003522795A5 (enExample) | 2008-03-06 |
Family
ID=26071832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001559472A Pending JP2003522795A (ja) | 2000-02-15 | 2001-02-15 | ノルエチステロンからなる男性用避妊製剤 |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP1267885B8 (enExample) |
| JP (1) | JP2003522795A (enExample) |
| KR (1) | KR20020086905A (enExample) |
| CN (1) | CN1423560A (enExample) |
| AT (2) | ATE355844T1 (enExample) |
| AU (1) | AU2001230447A1 (enExample) |
| BG (1) | BG107066A (enExample) |
| BR (1) | BR0108411A (enExample) |
| CA (1) | CA2398063A1 (enExample) |
| CY (1) | CY1106639T1 (enExample) |
| CZ (1) | CZ20022691A3 (enExample) |
| DE (2) | DE60127103T2 (enExample) |
| DK (1) | DK1267885T3 (enExample) |
| EE (1) | EE200200454A (enExample) |
| ES (1) | ES2282230T3 (enExample) |
| HK (1) | HK1049442B (enExample) |
| HU (1) | HUP0300128A3 (enExample) |
| IL (1) | IL151219A0 (enExample) |
| MX (1) | MXPA02007675A (enExample) |
| NO (1) | NO20023607L (enExample) |
| PL (1) | PL357185A1 (enExample) |
| PT (1) | PT1267885E (enExample) |
| RU (1) | RU2002124602A (enExample) |
| SI (1) | SI1267885T1 (enExample) |
| SK (1) | SK11602002A3 (enExample) |
| WO (1) | WO2001060376A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10234525A1 (de) * | 2002-07-25 | 2004-02-05 | Schering Ag | Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung |
| TW200404552A (en) * | 2002-05-30 | 2004-04-01 | Akzo Nobel Nv | Self administered contraception |
| EA008147B1 (ru) | 2002-07-24 | 2007-04-27 | Шеринг Акциенгезельшафт | МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ |
| CA2493207A1 (en) * | 2002-07-25 | 2004-02-05 | Schering Aktiengesellschaft | Composition containing an androgenous 11.beta.-halogen steroid and a progestational hormone, and male contraceptive based on said composition |
| JO2505B1 (en) * | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
| CN101352443B (zh) * | 2007-07-23 | 2011-01-12 | 中国科学院动物研究所 | 哺乳动物雄性不育剂 |
| EP3750538B1 (en) | 2018-03-23 | 2024-08-14 | Pharmajor International | Non-hormonal methods for male contraception comprising (r)-silodosin |
| KR20250142811A (ko) * | 2024-03-22 | 2025-09-30 | 주식회사 에아스텍 | 노르에티스테론 에난테이트 화합물의 암의 예방 또는 치료 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714420A1 (de) * | 1976-06-01 | 1977-12-08 | Int Pregnancy Advisory Service | Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung |
| US4210644A (en) | 1978-02-23 | 1980-07-01 | The Johns Hopkins University | Male contraception |
| US5035891A (en) | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
| CN1102095A (zh) * | 1993-10-30 | 1995-05-03 | 浙江医科大学 | 长效雄激素类制剂——十一酸睾丸注射液 |
| DE19650352A1 (de) * | 1996-12-04 | 1998-07-30 | Jenapharm Gmbh | Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann |
-
2001
- 2001-02-15 HK HK03101578.5A patent/HK1049442B/en not_active IP Right Cessation
- 2001-02-15 AT AT01902590T patent/ATE355844T1/de active
- 2001-02-15 DK DK01902590T patent/DK1267885T3/da active
- 2001-02-15 WO PCT/IB2001/000188 patent/WO2001060376A1/en not_active Ceased
- 2001-02-15 IL IL15121901A patent/IL151219A0/xx unknown
- 2001-02-15 PL PL01357185A patent/PL357185A1/xx not_active Application Discontinuation
- 2001-02-15 DE DE60127103T patent/DE60127103T2/de not_active Expired - Lifetime
- 2001-02-15 CA CA002398063A patent/CA2398063A1/en not_active Abandoned
- 2001-02-15 RU RU2002124602/15A patent/RU2002124602A/ru not_active Application Discontinuation
- 2001-02-15 BR BR0108411-9A patent/BR0108411A/pt not_active IP Right Cessation
- 2001-02-15 AT AT06075322T patent/ATE474580T1/de not_active IP Right Cessation
- 2001-02-15 CZ CZ20022691A patent/CZ20022691A3/cs unknown
- 2001-02-15 SK SK1160-2002A patent/SK11602002A3/sk unknown
- 2001-02-15 KR KR1020027010715A patent/KR20020086905A/ko not_active Withdrawn
- 2001-02-15 AU AU2001230447A patent/AU2001230447A1/en not_active Abandoned
- 2001-02-15 EE EEP200200454A patent/EE200200454A/xx unknown
- 2001-02-15 CN CN01808041A patent/CN1423560A/zh active Pending
- 2001-02-15 EP EP01902590A patent/EP1267885B8/en not_active Expired - Lifetime
- 2001-02-15 DE DE60142647T patent/DE60142647D1/de not_active Expired - Lifetime
- 2001-02-15 EP EP06075322A patent/EP1666044B1/en not_active Expired - Lifetime
- 2001-02-15 ES ES01902590T patent/ES2282230T3/es not_active Expired - Lifetime
- 2001-02-15 MX MXPA02007675A patent/MXPA02007675A/es unknown
- 2001-02-15 SI SI200130726T patent/SI1267885T1/sl unknown
- 2001-02-15 HU HU0300128A patent/HUP0300128A3/hu unknown
- 2001-02-15 JP JP2001559472A patent/JP2003522795A/ja active Pending
- 2001-02-15 PT PT01902590T patent/PT1267885E/pt unknown
-
2002
- 2002-07-30 NO NO20023607A patent/NO20023607L/no not_active Application Discontinuation
- 2002-09-05 BG BG107066A patent/BG107066A/xx unknown
-
2007
- 2007-06-05 CY CY20071100743T patent/CY1106639T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2558030T3 (es) | Método anticonceptivo oral multifásico de ciclo prolongado | |
| BRPI0512991A (pt) | uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto | |
| WO2013016697A3 (en) | 17-hydroxyprogesterone ester-containing oral compositions and related methods | |
| WO2004080383A3 (en) | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels | |
| AU2681300A (en) | Solid oral dosage form containing an enhancer | |
| AR073972A2 (es) | Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas | |
| BR0010485A (pt) | Formulações de derivados de eritromicina de liberação prolongada | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| AR022254A1 (es) | Composicion de administracion oral. | |
| WO2007145991A3 (en) | Anti-inflammatory and analgesic compositions and related methods | |
| CA2467237A1 (en) | Method of preventing or treating benign gynaecological disorders | |
| JP2004519488A5 (enExample) | ||
| RU2009120528A (ru) | Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла | |
| WO2001032596A8 (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
| DE69908304D1 (de) | Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen | |
| GR3035613T3 (en) | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids | |
| RU2001101892A (ru) | Производное тестостерона | |
| JP2003508467A5 (enExample) | ||
| RU2003107072A (ru) | Применение гормональной композиции, содержащей сочетание эстрогена и прогестагена | |
| PT1227814E (pt) | Composicao hormonal a base de acetato de nomegestrol e de um estrogenio e sua utilizacao | |
| MX2007013137A (es) | Regimen anticonceptivo con dosificacion de estrogeno ampliada. | |
| JP2001354558A5 (enExample) | ||
| WO2000054780A3 (en) | Corticosteroid formulation | |
| JP2008522972A5 (enExample) | ||
| JP2003521457A5 (enExample) |